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Abstract: The membrane translocation efficiency of cell penetrating peptides (CPPs) has been largely
studied, and poly-arginines have been highlighted as particularly active CPPs, especially upon negatively
charged membranes. Here we inquire about the influence of membrane mechanical properties in
poly-arginine adsorption, penetration and translocation, as well as the subsequent effect on the
host membrane. For this, we selected anionic membranes exhibiting different rigidity and fluidity,
and exposed them to the nona-arginine KR9C. Three different membrane compositions were investigated,
all of them having 50% of the anionic lipid 1,2-dioleoyl-sn-glycero-3-phospho-(1’-rac-glycerol) (DOPG),
thus, ensuring a high affinity of the peptide for membrane surfaces. The remaining 50% was a saturated
PC (1,2-dipalmitoyl-sn-glycero-3-phosphocholine, DPPC), an unsaturated PC (1,2-dioleoyl-sn-glycero-3
-phosphocholine, DOPC) or a mixture of DOPC with cholesterol. Peptide-membrane interactions were
studied using four complementary models for membranes: Langmuir monolayers, Large Unilamellar
Vesicles, Black Lipid Membranes and Giant Unilamellar Vesicles. The patterns of interaction of KR9C
varied within the different membrane compositions. The peptide strongly adsorbed on membranes with
cholesterol, but did not incorporate or translocate them. KR9C stabilized phase segregation in DPPC/DOPG
films and promoted vesicle rupture. DOPC/DOPG appeared like the better host for peptide translocation:
KR9C adsorbed, inserted and translocated these membranes without breaking them, despite softening
was observed.
Keywords: cell penetration peptides; liquid-ordered phase; membrane heterogeneities; membrane rheology
1. Introduction
Cellular membranes regulate lateral di↵usion of the lipids and proteins associated to them,
compartmentalization and permeability. It has been shown that organisms adapt the lipid composition
of their membranes in order to maintain them mainly in a fluid state [1]. Notwithstanding, several studies
performed in plasma and internal membranes point to the existence of regions with di↵erent
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compositions, which leads to local di↵erences in mechanical properties. While the presence of
membrane proteins has been related to solid docks [2], sterols are accepted as liquid-ordered phase
inducers [3]. Thus, the current model for membranes is a patchwork-like surface, with the di↵erent
regions being highly variable both, in size and in time [3].
Soluble molecules that interact with membranes, such as peptides may have a nities that depend
on membrane composition and rheology. As a consequence of the patchwork-like character of the
membrane, regions with a broad spectrum of properties are available for the interaction with soluble
peptides. Thus, it is important to know to what extent the peptide-membrane interactions depend on
membrane rheology, and also how the membrane mechanical properties change after the interaction
has taken place.
Cationic peptides have been widely investigated during the past years, and among other
classifications, they have been sorted into two groups: Antimicrobial peptides (AMPs) and cell
penetrating peptides (CPPs). The main di↵erence between these families is the peptide-lipid a nity,
which seems to be higher for the antimicrobial peptides. Besides, at low peptide concentrations AMPs
promote membrane lysis, while CPPs are able to cross membranes without largely a↵ecting their
properties [4,5]. As such, CPPs have become an invaluable tool in cell biology, allowing to introduce
CPP-functionalized cargoes into cells [6–8].
Since the discovery of CPPs [9,10], a significant amount of information has been obtained related
to their cell-permeability. Peptide amphipathicity, length and amino acid sequence have been pointed
out as important factors [7,11]. Basic residues enhance the e ciency of peptides to cross membranes.
Related to this, an extraordinary ability to passively penetrate cellular membranes has been reported for
arginine-rich polypeptides [12,13], the observation that coined the term “Arginine-magic” [11,14,15].
Lesser information is available in relation to how membrane properties a↵ect the CPP action.
Main observations so far include that CPP translocation is fostered by the presence of fatty acids [13,16],
as well as by lipids that form hexagonal II phase [17,18], whilst cholesterol (CHOL) hinders CPP
translocation [19,20].
With all these in mind, our aim was to inquire about how the a nity and consequent e↵ects of
the interaction between a CPP-like peptide and membranes are a↵ected by the membrane mechanical
properties. This kind of studies using lipid membranes is a first step towards understanding the
complex regulation of the interaction of membranes with soluble molecules by the membrane rheology,
as well as the subsequent e↵ect of the interaction on membrane mechanical properties. We studied
the interaction and the associated e↵ects of a polyarginine with binary membranes. Highly anionic
membranes were chosen (with 50% of 1,2-dioleoyl-sn-glycero-3-phospho-(1’-rac-glycerol), DOPG)
to assure lipid-peptide interaction with all membrane compositions. The other 50% was
a saturated lipid (1,2-dipalmitoyl-sn-glycero-3-phosphocholine, DPPC), an unsaturated lipid
(1,2-dioleoyl-sn-glycero-3-phosphocholine, DOPC) or a mixture of DOPC and CHOL. In this manner,
we studied monolayers in liquid-condensed/liquid-expanded or bilayers in gel/liquid-disordered
phase coexistence (DPPC/DOPG) [21], liquid-expanded monolayers or liquid-disorder bilayers
(DOPC/DOPG), and mixtures with CHOL, which induces more compact, but still fluid DOPC
membranes [22–24].
The selected peptide was a nona-arginine, since this length was found optimal regarding
translocation e ciency across lipid membranes [25]. We also included in the sequence a lysine and
cysteine residues, forming the peptide KR9C, with the aim of broadening its possible applications,
since these aminoacids allow to bind the polyarginine to proteins (lysine residue) and to gold surfaces
(cysteine residue).
We studied peptide insertion into Langmuir monolayers, adsorption on large and giant unilamellar
vesicles (LUVs and GUVs), and translocation through black lipid membranes (BLMs). Our results
indicate that membrane rheology is an important factor for peptide adsorption, incorporation
and subsequent translocation. KR9C peptide actively interacted with DPPC/DOPG: It adsorbed,
incorporated and crossed these membranes. However, phase segregation and membrane lysis
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were observed, pointing to rigid, but fragile membranes. On the other hand, the peptide did not
incorporate into membranes with CHOL, but it remained at their surfaces. Finally, favorable adsorption,
penetration and translocation were observed when this peptide was added to membranes formed
by the two unsaturated lipids. We observed that after CPP addition to DOPC/DOPG membranes,
vesicle shape fluctuations increased and the membrane resistance upon curvature changes became
weaker, pointing to a softening of the lipid bilayer.
2. Materials and Methods
KR9C and 5-FAM-KR9C 95% purity was purchased from Innovagen (Lund, Sweden). NaCl, polyvinyl
alcohol (PVA), n-decane, albumin (from bovine serum) and chloroform were obtained from Sigma-Aldrich
(St. Louis, MO, USA). Cholesterol (CHOL), 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC),
1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 1,2-dioleoyl-sn-glycero-3-phospho-(1’-rac-glycerol)
sodium salt (DOPG), 1,2-distearoyl-sn-glycero- 3-phosphoethanolamine-N-[biotinyl(polyethylene
glycol)-2000] ammonium salt (DSPE-PEG(2000) Biotin), and the lipophilic fluorescent
probe L-a-phosphatidylethanolamine-N-(lissamine rhodamine B sulfonyl) (ammonium salt)
(egg-transphosphatidylated chicken) (Rho-PE) were obtained from Avanti Polar Lipids (Alabaster,
AL, USA). The chemical structure of the lipids is depicted in supplementary materials (Figure S1).
Streptavidin-coated micro-beads (3 µm) were purchased from Bangs Laboratories Inc. (Fishers, IN, USA),
Lipids were dissolved in 2:1 ratio chloroform:methanol (1 nmol/mL). All the solvents and chemicals
used were of the highest commercial purity available. Peptide and NaCl solutions were prepared
using deionized water with a resistivity of 18 MW cm, filtered with an Osmoion system (Apema, BA,
Quilmes, Argentina).
2.1. Methods
2.1.1. Monolayers at the Air-Water Interface
Compression isotherms and monolayer insertion experiments were performed in a NIMA 102M
(NIMA Technology, Coventry, UK) Langmuir balance, using the Wilhelmy method with a platinum
plate. The lipid monolayers were formed by spreading the lipids on a NaCl 150 mM solution prepared
at the water pH (about six, due to CO2 dissolution), and compressed at 1 ⇥ 10 2 nm2 molecule 1
min 1. Insertion studies were performed on a homebuilt trough with 1 mL capacity. The lipid solution
was spread, drop by drop, onto the subphase until reaching the desired initial surface pressure (⇡0).
Following solvent evaporation (5 min), an aliquot of the peptide solution was injected in the subphase
through a hole in the wall of the trough. The final concentration of the peptide was 10µM, as this
concentration was previously found to be the minimum necessary to saturate the incorporation of KR9C
into perfluorotetradecanoic acid monolayers [26]. Time evolution of the surface pressure was registered
after the addition of the peptide and its final value, ⇡f, was determined from the asymptote of the curve.
The change in surface pressure was defined as D⇡ = ⇡f   ⇡0. All the experiments were performed
at 25 ± 1  C. Langmuir monolayers were observed with a direct microscope (Axioplan, Carl Zeiss,
Oberkochen, Germany) with 20⇥ objective (air immersion) and a CCD video camera Axio CamHRc
(Carl Zeiss, Oberkochen, Germany). In these experiments, 0.5 mole% of Rho-PE was included in the
lipid mixtures.
2.1.2. Large Unilamellar Vesicles (LUVs), Hydrodynamic Size and Z-Potential Measurements
A uniform lipid film was formed on the wall of a glass tube by solvent evaporation under an N2
flow from a chloroform:methanol lipid solution. Final traces of solvent were removed by incubating
the lipids in a high-vacuum chamber for 1 h. Then, the lipids were resuspended in the aqueous solution
of NaCl 1 mM, to a final concentration of 0.3 mM. The suspension was incubated in a 50  C water
bath for 30 s, after that, it was vortexed and subjected to cold incubation for 30 s. This procedure was
Biomolecules 2019, 9, 625 4 of 18
repeated nine times. The resulting multilamellar vesicles were extruded 21-times through a 100 nm
pore filter (Avanti) at 50  C.
For the z potential and dynamic light scattering (DLS) measurements, the 0.3 mM lipid dispersion
was diluted to a final concentration of 0.12 mM. Then, an appropriate volume of a stock solution of
the peptide was added to 100 µL of this dilution to achieve the desired peptide to lipid molar ratio
(P/L), and incubated for 1 h. The z-potential determinations were performed by means of Henry’s
equation, subjecting aliquots of 100 µL of liposomes and peptide to an electric field and determining
electrophoretic mobility with Z-sizer SZ-100-Z equipment (Horiba, Ltd., Kyoto, Japan).
In order to calculate the P/L ratio, the amount of phospholipid was quantified using the
Bartlett’s method [27]. This is, phospholipids were digested, and inorganic phosphorus was
quantified colorimetrically. Absorbance was measured with a Shimadzu UV-visible Spectrophotometer
(Biospec-mini, Chiyoda-ku, Tokyo, Japan) at   = 830 nm.
2.1.3. Giant Unilamellar Vesicles (GUVs)
A 100 µL aliquot of a 5% (W/W) solution of PVA in water was spread on the glass base of a Petri
dish, and dried for 1 h at 50  C. Ten microliters of a 2.5 µg/mL lipid solution doped with 0.5 mole% of
the fluorescent probe Rho-PE were spread onto the PVA film, subjected to vacuum for 1 h for solvent
evaporation, and hydrated with 300mM sucrose in 15 mM NaCl. GUV formation was corroborated after
1 h with optical microscopy using a confocal fluorescence microscope (Confocal Zeiss FV1000) with a
60⇥ objective (immersion in oil). For observations, an aliquot of the GUV suspension was transferred
to the observation chamber containing 300 mM glucose in 15 mM NaCl. Previously, the observation
chamber was treated with a 10% (w/v) of albumin solution, which prevented the rupture of GUVs on
the glass slide. Osmolarity parity between sucrose and glucose solutions was tested with an automatic
micro-osmometer OM-806 (Vogel, Germany).
For peptide adsorption determinations, 1.2 or 3µL of the fluorescently labeled peptide 5-FAM-KR9C
(200 µM) were gently added to 240 µL of the GUV’s suspension in the observation chamber, and the
increase in fluorescence intensity at the membrane surface, and in the GUV’s surroundings was
followed over time. For this, we determined the grey level inside 3–5 ROIs close to each GUV and at
the GUV’s rim along with a stack of images and plotted this data as a function of time, starting from
the time where the fluorescence increased, as exemplified in supplementary materials (Figure S2).
Shape fluctuations were determined for the GUVs composed of DOPC/DOPG, registering 15 20
individual GUVs through time (100 frames, 38 frames/min) as detailed in ref. [28]. Briefly, for each vesicle,
the value of the aspect ratio (AR = longer axis length/minor axis length) was determined along with the
videos, and the standard deviation of the AR values (SDAR) was statistically analyzed. Higher values of
SDAR represented vesicles with more fluctuating shapes than lower values. Each vesicle was classified
as “fluctuating” or “non-fluctuating” depending on the value of SDAR. For this, a reference value of
SDAR was defined as the P95th value (the value below which 95% of the data are found) of SDAR in the
control condition (without peptide). With this reference value, each GUV was considered “fluctuating”
if the SDAR value was higher than the reference one or else, “non-fluctuating”. The percent of
fluctuating GUVs was calculated as the number of fluctuating GUVs divided by the total number
of analyzed GUVs. This procedure was performed in two independent sets of experiments and the
averages ± SE are shown. A set of data is shown in supplementary materials (Figure S3).
For the nano-tube retraction experiments, the lipid solutions contained 1 ⇥ 10 4 mole%
of a biotinylated lipid (DSPE-PEG(2000) Biotin). An aliquot of the GUV suspension was
transferred to a home-made observation chamber containing 300 mM glucose in 15 mM NaCl.
Previously, the observation chamber was treated with an avidin solution in order to attach GUVs and
prevent their motion. Nano-tubes were formed by attaching a streptavidin-coated micro-sphere to
the membrane, and moving the bead with an optical tweezer. Beads were previously cleaned by ten
consecutive cycles of centrifugation, pellet separation and resuspension in clean water.
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2.1.4. Optical Tweezer Setup
The optical trap was formed with the Gaussian beam from a 3W power ND:YVO4 laser
(Spectra-Physics, Santa Clara, CA, USA) focused through a 100⇥ objective (water immersion, NA = 1).
The tweezer was mounted in an Axiover 200 inverted microscope (Zeiss), in a similar manner to that
described by Lee et al. [29], and the experiments were registered with a fast CCD video camera (IxonEM+
model DU-897, Andor Technology, Abingdon, Oxfordshire, England). The original microscope stage
was replaced by a motorized one (BeijingWinner Optical Ins. CO., LTD, Langfang, Hebei, China),
in order to move the GUV attached to the cover-slip in a controlled manner. The trapped bead
was then separated from the GUV’s surface, thus, generating the membrane nano-tube. The trap
was turned o↵ with a shutter after a 20–30 µm length nano-tube was generated, and the retraction
process was recorded. Three to nine nanotubes were generated from each GUV before and after
addition of 2 µL of the peptide (final concentration 0.25 µM). Retraction kinetics was recorded and
analyzed, and the data shown correspond to the average ± SE obtained from two di↵erent GUVs in
two independent experiments.
2.1.5. Bilayer Lipid Membrane (BLM)
Black lipid membranes (BLMs) were formed in a polysulfone cuvette with a 150µm-aperture
inserted into a hold in a black Derlin chamber (model CF13A-150 and BCH-M13, Warner Instruments Inc.,
Hamden, CT, USA). The electrical recordings were performed with a potentiostat/galvanostat Autolab
PGSTAT30, equipped with impedance (FRA) and low current (ECD) modules. Current and potential
data were acquired using NOVA 2.1.2 software booth Metrohm Autolab B. V. The electrochemical
cell was formed immersing in the cis compartment a Pt wire (counter electrode) and Ag+/AgCl/Cl 
(reference electrode) and in the trans compartment a Pt wire (working electrode), as previously
performed by Khan et al. [30].
An aliquot of the lipid mixtures in chloroform was dried under N2 stream and put under vacuum
for 1 h for solvent removal. After this, lipids were resuspended in the corresponding volume of n-decane
to a final concentration of 25 mg/mL. BLM was formed by pre-coating the hole with lipid/n-decane
solution from the cis side using a glass sphere. After the lipid solution was dried, both compartments
were filled with 1mL NaCl 150 mM, previously filtered through a 0.2 µm nylon filter. Then, the cis side
of the hole was painted once more with lipid/n-decane solution [31].
Bilayer formation was tested by impedance spectroscopy 30 min after painting. The presence of
the BLM leads to an increase in the resistance from MW (in the absence of the bilayer) to GW range (in
the presence of the bilayer), together with a capacitance value between 0.4–0.9 µF/cm2. Resistance and
Capacitance values were obtained by fitting the experimental data with equivalent electrical models
for planar bilayer [30,32]. The used equivalent circuit, together with representative plots, is shown in
supplementary materials (Figure S4).
After corroborating the presence of a stable bilayer, chronoamperometry measurements were
performed. The bilayer was left for 600 s at 0V with respect to the open circuit potential (OCP), and
after this, a +150 mV (with respect to OCP) was applied. After other 600 s, 3 µL of 366 µM peptide
was added to the cis compartment reaching a final concentration of 1 µM. The current was registered
continuously, and the change in current after peptide addition was taken as a measure of membrane
permeability and peptide translocation. See representative recordings in supplementary materials
(Figure S5).
For each membrane composition, 5 or 6 independent experiments were performed, and the results
shown are the average ± SD. Membrane breakdown, due to the applied potential was not observed
in our experiments, and the level of noise in the current recordings remained unchanged at 150 mV
compared to 0V. We, thus, assumed that the applied potential did not a↵ect the state of the membrane,
as previously reported in DOPC/DPPC bilayers [33]. The chamber and cup were cleaned following the
protocol described by Warner instruments, washing several times with a sodium phosphate tribasic
solution (50mM), HCl 0.1 % w/v and ultra-pure water.
Biomolecules 2019, 9, 625 6 of 18
3. Results
3.1. KR9C Recruits DOPG and Does Not Incorporate into Membranes with Cholesterol
With the aim of studying the interaction of CPPs with membranes of di↵erent mechanical
properties, we studied the incorporation of KR9C into monolayers that contained DOPG and
DOPC, DPPC or DOPC/CHOL (see chemical structures in Figure S1 from supplementary). A high
percentage of the anionic lipid was included (50%) in order to assure the lipid-peptide attraction.
All experiments were performed using the following membrane compositions: DPPC/DOPG 1:1
(liquid-condensed/liquid-expanded-see below- or gel/liquid-disordered phase coexistence [21]),
DOPC/DOPG 1:1 (liquid-expanded or liquid-disordered membranes) or DOPC/CHOL/DOPG 3:2:5
(more compact than in the absence of CHOL, but still fluid membranes [22]).
The incorporation of KR9C was also studied in monolayers composed of the pure lipids.
Monolayers were prepared at the desired surface pressure (⇡o), and after equilibration, the peptide was
injected into the subphase to a final concentration of 10 µM. In the absence of monolayer, the surface
tension remained constant after peptide addition. In the presence of monolayers, the surface pressure
was recorded over time. The total pressure changes (D⇡ = ⇡f   ⇡o) induced by the peptide are
summarized in Figure 1a for all monolayer compositions except for CHOL and DOPC/CHOL/DOPG
3:2:5, where no change in surface tension was detected. This indicates that KR9C did not incorporate
into these monolayers, although the interaction of the peptide with the polar head-groups of the lipids
cannot be ruled out.
For all other compositions, an increase in surface pressure was observed, with the highest D⇡
values being for DOPG and DOPC/DOPG films, and the lowest for DPPC. The exclusion surface
pressure (⇡e) is the highest ⇡ value at which the peptide is able to penetrate the monolayer. This value
was higher for the DOPC/DOPG and DPPC/DOPG mixtures than for the corresponding pure lipids,
pointing to a synergistic e↵ect of the lipids in the binary systems. For these two mixtures, and also for
pure DOPG, ⇡e was higher than 30 mN/m, where the lipid density is proposed to be comparable to
that in bilayers [34–36]. Therefore, insertion of the peptide in bilayers of these compositions is likely to
occur. Pure DPPC and DOPC films depicted lower ⇡e as expected, since electrostatics is known to
enhance CPP incorporation [37–39]. The insertion occurred up to higher ⇡e values in DOPC than in
DPPC, indicating that KR9C incorporation is more favorable in the fluid than in more rigid membranes.
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Figure 1. Insertion of KR9C into monolayers of the indicated composition (average ± SD of at least
thr e experiments). Changes in surface pre sure (a), or in mean molecular area (b) upon addition of
10 µ of peptide as a function of the initial surface pressure. The open symbols in panel (b) were
calculated from data obtained from the linear fit in panel (a). ⇡e is the value of ⇡ in which D⇡ = 0.
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D⇡ depends on the amount of peptide incorporated, on the rearrangement caused by the peptide
on the surrounding lipids, and on the sti↵ness of the monolayer (i.e., the surface pressure response
of the film, due to a change in the area per lipid). In order to better compare the e↵ect of peptide
incorporation into DOPC/DOPG and DPPC/DOPG films (which depict di↵erent sti↵ness), we estimated
the change in the mean molecular area occupied by the lipids not a↵ected by the peptide upon
incorporation of the peptide, DA. This was calculated with the mean molecular areas obtained from
the compression isotherms of the pure lipids at ⇡o and at ⇡f, as detailed in supplementary materials
(Figure S6) [16]. Figure 1b shows the percentage of area change, DA/A0% (A0 is the mean molecular
area of the lipids at ⇡o) as a function of ⇡0. The open symbols were calculated with the data of D⇡
extrapolated from the linear fitting in Figure 1a. Changes in the area observed in monolayers of
DOPC/DOPG at high compactions were larger than in DPPC/DOPG monolayers, and thus, a larger
amount of KR9C incorporated, and/or a larger perturbation was observed in these fluid films, compared
to the more rigid DPPC/DOPG films.
The interaction of the peptide with monolayers was also followed by fluorescence microscopy in
order to check the presence of coexisting phases. In these experiments, the lipid mixtures contained
0.5% of the Rho-PE fluorescent probe. The monolayers of the three compositions were first observed
during compression, being DOPC/DOPG and DOPC/CHOL/DOPG homogeneous in the whole range,
whilst phase coexistence was detected in DPPC/DOPG films at surface pressures higher than 27 mN/m.
This is a consequence of the DPPC phase transition from liquid-expanded to liquid-condensed, as can
be inferred from the compression isotherm, shown in supplementary materials (Figure S6). The phase
transition shifted from 9.5 mN/m for pure DPPC to 27 mN/m for the 1:1 mixture with DOPG.
In order to study the e↵ect of KR9C on the film’s texture, monolayers with Rho-PE were formed
at an initial surface pressure of 30 mN/m, and the peptide was injected in the subphase at a final
concentration of 10 µM. Films of DOPC/DOPG and DOPC/CHOL/DOPG remained homogeneous
after peptide addition (data not shown), whilst in DPPC/DOPG monolayers, the domains increased
in size and number (see Figure 2), with a kinetic similar to that of the change in surface pressure
(~30 min, data not shown). At 30 mN/m, the presence of the peptide increased the surface pressure
in about 1 mN/m (see Figure 1a). This increase would lead to a negligible increase in the percent of
the area occupied by the liquid-condensed domains, and not to the 25% increase, shown in Figure 2b.
Thus, the increment in the area occupied by the lipids in the liquid-condensed phase was induced by the
peptide, which promoted the presence of compact regions in the monolayer where the fluorescent probe
was not soluble. Given that KR9C incorporated preferentially into less rigid monolayers (compare the
changes in surface pressure-induced in DOPC and in DPPC in Figure 1a), it is not expected that the
dark regions correspond to regions enriched in the peptide. Considering that KR9C incorporation was
more favorable into DOPG than into DPPC films (Figure 1a), we hypothesize that the peptide recruited
DOPG lipids, and consequently the film regions without peptide became depleted of this lipid. As a
result, the regions of the monolayer where the peptide did not incorporate became enriched in DPPC.
This enrichment would lead to a shift of the surface pressure for phase transition towards that of pure
DPPC, thereby stabilizing the liquid-expanded phase at 30 mN/m.
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3.2. KR9C Increases the Conductivity of DPPC/DOPG and DOPC/DOPG Membranes, without A↵ecting Those
with Cholesterol
The absence of CPP insertion into the monolayers containing CHOL, together with previous reports
performed with similar peptides [19,20] suggests that KR9C is unable to cross through membranes with
CHOL. However, monolayers are model membranes with a single leaflet, thus, lacking the geometry for
translocation that is present in bilayers submerged into two aqueous milieus. Therefore, we measured
the change in electrical conductivity of the membranes induced by the peptide in planar free-standing
bilayers composed of DOPG/DOPC, DPPC/DOPG and DOPC/CHOL/DOPG. For this, we used BLMs
separating two aqueous compartments. The BLMs were subjected to a potential of 150 mV, and the
current was registered before and after the addition of 1 µM peptide. Representative experiments are
shown in supplementary materials. The change in membrane conductivity induced by the peptide
is plotted in Figure 3. As can be observed, the conductivity increase in DOPG/DOPC membranes
was similar to that in DPPC/DOPG, and 3-times lower in the presence of CHOL. From these results,
we conclude that CHOL not only hinders peptide incorporation into a hemilayer, according to the
observations reported in the previous section, but also precludes peptide translocation.
In the case of DPPC/DOPG membranes, the increase in conductivity induced by the peptide may
be explained not only considering peptide translocation, but also due to an increase in membrane
defects as a consequence of the stabilization of the phase coexistence induced by the peptide. This kind
of defects has been proposed to be present during phase transitions [40,41].
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Figure 3. Increase in conductivity of black lipid membranes (BLMs) of the indicated compositions
after addition of 1 µM KR9C. ANOVA test indicated that there is at least one di↵erent ata with a 5%
confidence (↵ = 0.05); the obtained * p-value was 0.01. The asterisk denotes a statistically significant
di↵erence between 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC)/ cholesterol (CHOL)/DOPG and
DOPC/DOPG and DPPC/DOP, according to the Tukey test
3.3. KR9C Adsorbs at the Surfaces of the Three Membrane Compositions
The results shown up to now suggest that KR9C did n t incorporate or translocate membranes
with CHOL. However, adsorption at the interface may still occur, especially considering that 50% of
the lipids correspond to anionic species. In order to test the ability of the peptide to adsorb on the
membrane surfaces, 100 nm-sized LUVs were exposed to increasing amounts of the peptide, and the
potential at the slipping plane (z-potential, ⇣) was determined. At all the tested peptide concentrations,
LUVs remained intact as detected by Dynamic Light Scattering (see Figure S7 in supplementary
materials). As expected, negative values of ⇣ were determined in the absence of peptide for the three
membrane compositions, (Figure 4). As the ratio of peptide to lipid increased, ⇣ values became less
negative, indicating peptide adsorption.
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Figure 4. Z-potential values for LUVs of the indicated compos tions incubated with increasing
concentration of KR9C. Average ± SD of two independent experiments.
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Table 1 lists the total change in ⇣ (D⇣ = ⇣(P/L = 0)   ⇣(P/L = saturation)), and the P/L value at
which half of the change in ⇣ occurred (P/L50) for each membrane composition. For DOPC/DOPG
and DPPC/DOPG compositions, partial neutralization was observed since ⇣ changed from  44 to
15 mV and from  64 to 8 mV respectively. For DOPC/CHOL/DOPG, ⇣ changed from  50 to 61 mV,
and thus, vesicles were highly charged both without peptide and at saturation, though with an opposite
charge. Regarding P/L50, it was an order of magnitude lower for DOPC/CHOL/DOPG, requiring higher
concentration for DPPC/DOPG and even higher for DOPC/DOPG.
Our studies with monolayers and BLMs indicated that KR9C did not insert or translocate in
membranes with CHOL. Thus, the increase in the ⇣ values is very likely due to the adsorption of the
peptide, accumulating in the LUV’s surface without internalization. This explains the lower P/L value
for saturation of these LUVs compared to DPPC/DOPG and DOPC/DOPG, as well as the higher change
in ⇣.
Table 1. Data from the z-potential measurements. Total change in the ⇣ value (D⇣) and peptide to lipid
ratio for half the total change in ⇣ (P/L50).
Membrane Composition D⇣ (mV) P/L
50
DOPC/DOPG 55 ± 1 0.030 ± 0.005
DPPC/DOPG 68 ± 2 0.017 ± 0.002
DOPC/CHOL/DOPG 108 ± 3 0.003 ± 0.001
3.4. Adsorption of 5-FAM-KR9C on Membranes with Cholesterol Is Faster and Occurs to Higher Extents than
on DOPC/DOPG Membranes
The kinetics of adsorption of the peptide on the membranes was followed with the fluorescently
marked peptide 5-FAM-KR9C using GUVs and confocal microscopy. GUVs contained 0.5% Rho-PE
as a fluorescent probe and were between 5 and 20 µm in diameter. At least 16–20 GUVs of each
composition were analyzed, and Figure 5a shows representative images. The time at which fluorescence
of 5-FAM-KR9C was detected at the vesicle’s rim was variable, since it depended on peptide di↵usion.
We determined the fluorescence outside each GUV over time and normalized the fluorescence at the
rim with the fluorescence outside it at each time, Grim = rim’s fluorescence/fluorescence outside the
GUV. Grim gives an insight of the excess peptide at or/and inside the membrane in relation to the bulk
peptide concentration (possible changes in the fluorescent emission of 5-FAM, due to changes in the
environment would also a↵ect Grim). 1 or 2.5 µM peptide was added, corresponding to P/L ratios greater
than 1 where ⇣ has already reached a plateau (Figure 4). Figure 5b,c show the typical profiles for Grim as
a function of time for GUVs of DOPC/DOPG and DOPC/CHOL/DOPG, respectively. The fluorescence
increased over time, until it reached a constant value. GUVs composed of DPPC/DOPG did not
reach a plateau, they were unstable upon peptide addition and exploded a minute after the peptide
concentration outside the GUV reached a constant value, being the maximal Grim value of about 2.
Therefore, this composition was excluded from this set of experiments. Himeno et al. observed the
formation of pores in DOPG/DPPC mixtures that was suppressed by the addition of salt, due to the
screening of the electric charge of DOPG [42]. Contrary to their results, we observed that GUVs became
more unstable when the peptide was added, although a partial neutralization was observed (see
Figure 3). Therefore, the instability induced by the peptide in DPPC/DOPG membranes was not related
to an electrostatic e↵ect. It may be related to the increase in DPPC-rich regions, which are expected to
be rigid, and thus, not able to deform easily when the peptide incorporated.
Plots as those depicted in Figure 5b,c were fitted with the exponential equation Grim = C(1   e kt+ A),
where A and C fit parameters that give account of the fluorescence values when the peptide reached the
membrane (Grim = 1) and at long times (maximal Grim value), respectively, and k is the e↵ective constant
for the kinetic of peptide accumulation at the membrane. Sharmin et al. studied the interaction of
CF-R9 with GUVs of DOPC/DOPG (8:2) and DOPC/CHOL/DOPG (6:4:2) and proposed a kinetic model
with three stages: Adsorption of the peptide in the external monolayer, transfer from the external to
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the internal monolayer, and desorption from the internal monolayer to the interior of the GUV [19].
With this in mind, peptide concentration at the membrane rim (and thereby, Grim may increase, due to
peptide adsorption and incorporation from the outside, and decrease, due to peptide desorption and
entry to the GUV lumen.
As already mentioned, 1 and 2.5 µM correspond to saturating peptide concentrations, and thus,
no significant increase in the rate of peptide-membrane interaction with concentration is expected
in this concentration range. In agreement to this, we found no significant di↵erences between the k
values at 1 and 2.5 µM, and thus, Table 2 shows the mean value for k at the two studied concentrations.
Table 2 also shows the maximum intensity observed at long times. From these data, we can draw two
conclusions. First, that the apparent kinetic for the peptide-membrane interaction process was slightly
faster in the presence of CHOL, the distribution of the obtained values is shown in supplementary
materials (Figure S8). Second, that the amount of 5-FAM-KR9C appears to accumulate at the membrane
in a greater extent in the presence of CHOL (the change in this parameter may also be a↵ected by
changes in the fluorescence emission of 5-FAM, due to a di↵erent environment when CHOL is present).
This is in agreement with the results found with the z-potential measurements.
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Figure 5. Interaction of 5-FAM-KR9C with giant unilamellar vesicles (GUVs) composed of DOPC/DOPG
and DOPC/CHOL/DOPG. (a) Representative images of a single DOPC/CHOL/DOPG GUV at the
indicated times after the outside fluoresce reached a constant value (2.5 µM peptide). Top panels:
Rho-PE, bottom panels: 5-Figure. (b) Grim = ratio of the fluorescence at the GUV’s rim and at regions
outside the GUV after addition of 2.5 µM peptide for membranes of DOPC/DOPG. (c) Grim after addition
of 2.5 µM peptide for DOPC/CHOL/DOPG membranes. (b,c) correspond to the data of a single GUV in
a representative experiment.
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Table 2. Parameters for the interaction between the fluorescently marked peptide and GUVs.
Apparent constant for the kinetics of adsorption (k), and maximal value of fluorescence at the
rim normalized by the fluorescence outside the GUV (Grim at long times).
Membrane Composition k 1/103 s 1 Grim at Long Times
1 µM 2.5 µM
DOPC/DOPG 3.1 ± 0.7 1.18 ± 0.07 1.4 ± 0.1
DOPC/CHOL/DOPG 4.9 ± 0.9 1.7 ± 0.3 4 ± 1
1 Mean ± SD of the average values at 1 and 2.5 µM peptide concentrations.
Considering the results reported in the literature and our own ones, the di↵erence in the values
of k between both compositions can be explained considering that the peptide penetrated into the
DOPC/DOPG GUVs, whilst it did not cross the membranes with CHOL. Thus, not only adsorption,
but also desorption into the GUV’s interior a↵ected the value of k in DOPC/DOPG membranes. On the
other hand, in DOPC/CHOL/DOPG membranes, k depends only on peptide adsorption on the vesicle
surface. Therefore, 5-FAM-KR9C accumulated more e ciently and faster at the DOPC/CHOL/DOPG
membrane rim. In this regard, Sharmin et al. found that the addition of 40% CHOL to DOPG/DOPC
(2:8) membranes increased about 3-times the equilibrium constant for CF-R9-membrane interaction.
Furthermore, we found that an increase in KR9C concentration leads to a more e cient accumulation
of the peptide on membranes with CHOL than on membranes without this lipid, note that the maximal
value for Grim increased 2.4-times in the presence of CHOL and only 1.2-times in its absence (Table 2).
3.5. KR9C Softens DOPC/DOPG Membranes
We further studied the e↵ect of the peptide on the mechanical properties of the host membrane
using the composition that showed adsorption and translocation without lysis, i.e., the membranes
composed of DOPC/DOPG. This study was performed by analyzing the thermal shape fluctuations of
the GUVs and using an active method. Figure 6a shows representative images for a GUV at di↵erent
times in the absence and in the presence of KR9C. It is evident from these images that the shape
of the GUV fluctuated more when the peptide was present. In order to quantify this observation,
we determined the aspect ratio (AR) of GUVs along with all frames in a video, and statistically analyzed
the standard deviation of this parameter (SDAR), as detailed in the Experimental Section. The value of
SDAR gives an insight into how much AR changes in time for a particular GUV. A histogram of the
values for SDAR at each peptide concentration for a set of experiments is shown in SI. The distribution
of values of SDAR shifted to a higher number as the peptide concentration increased; thus, the number
of GUVs with fluctuating shapes increased in the presence of the CPP.
We next classified GUVs as “fluctuating” or “not-fluctuating” and calculated the population
of fluctuating vesicles [28]. Figure 6b shows that the percentage of fluctuating GUVs increased in
the presence of the CPP, indicating that the energy cost for a shape change decreased when KR9C
was added.
To quantify the elasticity of the membrane upon undulations, we applied mechanical stress to
the GUVs by means of optical tweezers. Membrane nano-tubes were generated from GUVs before
and after the addition of low peptide concentrations (0.25 µM) and registered the retraction process
after the trap was turned o↵. Figure 7a shows a temporal image sequence of the retraction process,
from which nano-tube length was obtained. These data were plotted, as shown in Figure 7b, and fitted
in order to obtain the characteristic time for relaxation with an equation that neglects inertial terms [43]:
L(t) = L0 exp( t/⌧). Here, L0 and L are the initial nano-tube length and its temporal value, respectively.
The values for R-square for the fitting were within 0.91 and 0.98, being lower for the experiments in the
absence of peptide. The fitting was better at high nano-tube lengths than at the end of the experiment
(see the two examples in Figure 7b). This could be related to bead-vesicle interactions that were not
considered in the fitting model.
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active curvature perturbation, as well as thermal fluctuation, pointed to a softening of the membrane
in the presence of the peptide. Charged surfaces are known to be more rigid against undulations than
neutral ones [44–52]. Therefore, the decrease in membrane rigidity could be explained, considering that
the peptide partially neutralizes these membranes. Note that a 3-fold decrease in the absolute value of
the z-potential was observed in the presence of the peptide (Figure 4). Besides, it was reported that
the addition of DOPG to DOPC bilayers increases the bending rigidity of GUVs [53]. In this regard,
our hypothesis that KR9C recruited DOPG lipids in DPPC/DOPG membranes could also be considered
here, since peptide incorporation was favored in DOPG compared to DOPC monolayers (see Figure 1).
The recruiting of the anionic lipid in the regions close to the peptide would lead to an enrichment of
DOPC in other regions, subsequently decreasing the observed bending rigidity. Furthermore, ⌧ gives
an account of the viscosity to the elastic response of the system. In lipid bilayers, the viscosity term is
proposed to be negligible [54], and thus, in the absence of the peptide, this term corresponds to the
motion of the bead in the aqueous media. However, membrane viscosity may turn appreciable in the
presence of the peptide, thereby a↵ecting the value of ⌧.
Significant reduction in membrane bending rigidity has been reported in the presence of di↵erent
AMPs using a variety of hosts membrane compositions [51]. This observation has been explained
considering local membrane thinning, pore formation, higher lateral di↵usion, peptide-peptide
interactions, and/or inhomogeneous spontaneous curvature [55–60]. Addition of HIV-1 fusion peptide
to membranes also reduced the bending rigidity, and, in this case, a decoupling of the hemi-layers
induced by the peptide was proposed [61,62].
We here studied a hydrophilic CPP-like peptide that does not form stable pores in the membrane,
and very probably translocate through hydrophilic pores, in analogy to the closely related peptide
R9 [26]. Nonetheless, we cannot discard that some of the previously mentioned phenomena induced by
AMPs are also happening in our experiments, yielding softer membranes. Regarding CPPs, a moderate
reduction in the bending rigidity of DOPC membranes has recently been reported using molecular
dynamics. The authors suggested that the CPP ability to convey water molecules into the lipid bilayer
may be responsible for locally a↵ecting the membrane bending modulus [63]. Therefore, this may be
another explanation for the observed softening.
4. Conclusions
We investigated the interaction of KR9C, a CPP-like peptide, with anionic membranes of di↵erent
compositions: DOPC/DOPG (1:1), DPPC/DOPG (1:1) and DOPC/CHOL/DOPG (3:2:5). Our results
indicate that the cationic peptide adsorbs on the polar region of the three membranes, thereby reducing
the anionic charge and even turning it positively charged. The surface charge change was higher in
membranes with CHOL; also the fluorescently marked peptide showed higher fluorescence levels
in these membranes. Thus, peptide accumulation on the membrane surface was maximal for the
DOPC/CHOL/DOPG composition. However, the peptide did not insert into monolayers containing
CHOL, nor increased conductivity of BLMs with CHOL. Therefore, we conclude that the decrease in
permeability that is known to induce the presence of CHOL in membranes is able to preclude CPP
translocation, despite the fact that the anionic membrane concentrates it on its surface. This is in
agreement with previous results [19,20].
Monolayers composed of PC and DOPG (both, with the saturated DPPC and the unsaturated
DOPC) were able to incorporate KR9C, even more than the pure lipids. The cut-o↵ surface pressure
was higher for DOPC/DOPG than for DPPC/DOPG monolayers, in both cases being higher than
30 mN/m, where the molecular density is similar to that in bilayers [34,35]. In DPPC/DOPG monolayers,
an increase in the size and number of condensed domains was observed. This process occurred with a
similar kinetic than that for the surface pressure increase (~half hour) and slower than the kinetics of
adsorption of the fluorescent peptide before vesicle burst (~one minute). Thus, the peptide absorbed
fast to the film, and the subsequent insertion promoted a slow reorganization of the monolayer with an
associated phase transition.
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This was explained proposing that the CPP recruited PG lipids, thus, enriching the rest of
the monolayer in DPPC and thereby decreasing the surface pressure for the liquid-expanded to
the liquid-condensed phase transition. This is expected because peptide penetration into DOPG
monolayers was more favorable than into DPPC monolayers.
The conductivity increase induced by KR9C on DPPC/DOPG and DOPC/DOPG membranes was
similar. However, we propose that in the case of the saturated PC, the increase in the conductivity is
related to an increase in membrane defects instead of peptide translocation. This is proposed because
DPPC/DOPG GUVs were unstable and exploded in the presence of the peptide, and also because phase
coexistence was favored by the peptide in Langmuir monolayers.
The membranes composed of DOPC/DOPG showed good peptide insertion, with a significant
increase in membrane conductivity and high stability upon vesicle lysis. In the presence of KR9C,
these membranes got softer upon out-of-plane deformations. This was explained assuming that the
peptide recruited DOPG, thus, leading to a DOPC enriched membrane. Besides, peptide adsorption
leads to partial membrane neutralization, which may also contribute to the decrease in bending
rigidity. Other explanations, such as the incorporation of water in the membrane coupled with peptide
translocation, increase in membrane viscosity and local membrane thinning cannot be discarded.
In a cell membrane, a great variety of compositions coexist transiently in small patches, each one
with di↵erent mechanical properties. Thus, pre-concentration of CPP may occur in a region enriched
in CHOL, whilst the peptide inserts in a neighbor region depleted of CHOL. Under this point of view,
the patchwork like the organization of the membrane would act synergistically enhancing peptide
translocation. Regarding the softening e↵ect promoted by the peptide on membranes, this could trigger
in cells the activation/deactivation of metabolic pathways leading to changes in the lipidic composition
of membranes in order to counteract the e↵ect of the peptide.
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accumulation at the membrane.
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